Danielle Townsley

902 total citations
12 papers, 115 citations indexed

About

Danielle Townsley is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Danielle Townsley has authored 12 papers receiving a total of 115 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 5 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Danielle Townsley's work include Hematopoietic Stem Cell Transplantation (5 papers), CAR-T cell therapy research (2 papers) and Epigenetics and DNA Methylation (2 papers). Danielle Townsley is often cited by papers focused on Hematopoietic Stem Cell Transplantation (5 papers), CAR-T cell therapy research (2 papers) and Epigenetics and DNA Methylation (2 papers). Danielle Townsley collaborates with scholars based in United States, United Kingdom and Brazil. Danielle Townsley's co-authors include Neal S. Young, Bogdan Dumitriu, Olga Rios, Priscila Scheinberg, Phillip Scheinberg, Colin O. Wu, Barbara Weinstein, Maithili M. Daphtary, Maher Albitar and Cynthia E. Dunbar and has published in prestigious journals such as Blood, Cancer Research and Clinical Pharmacology & Therapeutics.

In The Last Decade

Danielle Townsley

11 papers receiving 113 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Danielle Townsley United States 6 77 30 23 18 17 12 115
Norihiro Murakami Japan 6 43 0.6× 27 0.9× 16 0.7× 19 1.1× 8 0.5× 12 100
Aditi Vedi United Kingdom 5 43 0.6× 37 1.2× 31 1.3× 22 1.2× 23 1.4× 17 129
Samantha Nichele Brazil 6 89 1.2× 52 1.7× 41 1.8× 38 2.1× 26 1.5× 14 152
Hayato Tamai Japan 6 60 0.8× 78 2.6× 28 1.2× 32 1.8× 15 0.9× 19 145
Nils B. Leimkühler Germany 5 40 0.5× 42 1.4× 21 0.9× 33 1.8× 8 0.5× 8 114
Einar Haukås Norway 4 108 1.4× 27 0.9× 17 0.7× 27 1.5× 15 0.9× 17 129
Shunsuke Yui Japan 6 68 0.9× 34 1.1× 16 0.7× 22 1.2× 4 0.2× 18 111
Sushree Sangita Sahoo United States 6 91 1.2× 35 1.2× 8 0.3× 37 2.1× 40 2.4× 13 136
Marioara F. Ciuculescu United States 6 28 0.4× 39 1.3× 13 0.6× 11 0.6× 19 1.1× 12 91
Asif Alavi United States 6 41 0.5× 26 0.9× 17 0.7× 12 0.7× 12 0.7× 14 74

Countries citing papers authored by Danielle Townsley

Since Specialization
Citations

This map shows the geographic impact of Danielle Townsley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danielle Townsley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danielle Townsley more than expected).

Fields of papers citing papers by Danielle Townsley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danielle Townsley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danielle Townsley. The network helps show where Danielle Townsley may publish in the future.

Co-authorship network of co-authors of Danielle Townsley

This figure shows the co-authorship network connecting the top 25 collaborators of Danielle Townsley. A scholar is included among the top collaborators of Danielle Townsley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danielle Townsley. Danielle Townsley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
2.
Sharma, Shringi, Xavier Pépin, Jean Cheung, et al.. (2022). Bioavailability of acalabrutinib suspension delivered via nasogastric tube in the presence or absence of a proton pump inhibitor in healthy subjects. British Journal of Clinical Pharmacology. 88(10). 4573–4584. 3 indexed citations
3.
Revette, Anna, Heidi D. Klepin, Amer M. Zeidan, et al.. (2020). Consensus minimum hemoglobin level above which patients with myelodysplastic syndromes can safely forgo transfusions. Leukemia & lymphoma. 61(12). 2900–2904. 8 indexed citations
4.
Dy, Grace K., Diwakar Davar, Evanthia Galanis, et al.. (2020). Abstract CT244: A phase 1 study of IV MEDI5395, an oncolytic virus, in combination with durvalumab in patients with advanced solid tumors. Cancer Research. 80(16_Supplement). CT244–CT244. 5 indexed citations
5.
Jung, Moonjung, Stefan Cordes, Jizhong Zou, et al.. (2018). GATA2 deficiency and human hematopoietic development modeled using induced pluripotent stem cells. Blood Advances. 2(23). 3553–3565. 25 indexed citations
6.
Giudice, Valentina, Angélique Biancotto, Zhijie Wu, et al.. (2018). Aptamer-based proteomics of serum and plasma in acquired aplastic anemia. Experimental Hematology. 68. 38–50. 15 indexed citations
7.
Giudice, Valentina, Xin Zhao, Zhijie Wu, et al.. (2016). Crispr/Cas9-Induced DNMT3A Mutations in the K562 Human Leukemic Cell Line As a Model of DNMT3A-Mutated Leukemogenesis. Blood. 128(22). 2704–2704. 1 indexed citations
8.
Winkler, Thomas, Danielle Townsley, Ronan Desmond, et al.. (2016). Successful Treatment of a Diamond-Blackfan Anemia (DBA) Patient with Eltrombopag. Blood. 128(22). 2682–2682. 3 indexed citations
9.
Albitar, Adam, Danielle Townsley, Wanlong Ma, et al.. (2016). Higher Mutation Rate in Patients with Aplastic Anemia Using Peripheral Blood cfDNA As Compared with Bone Marrow Cells. Blood. 128(22). 3902–3902. 1 indexed citations
10.
Scheinberg, Phillip, Danielle Townsley, Bogdan Dumitriu, et al.. (2014). Horse antithymocyte globulin as salvage therapy after rabbit antithymocyte globulin for severe aplastic anemia. American Journal of Hematology. 89(5). 467–469. 22 indexed citations
11.
Scheinberg, Phillip, Danielle Townsley, Bogdan Dumitriu, et al.. (2014). Moderate-dose cyclophosphamide for severe aplastic anemia has significant toxicity and does not prevent relapse and clonal evolution. Blood. 124(18). 2820–2823. 30 indexed citations
12.
Dumitriu, Bogdan, Xingmin Feng, Yutaka Ueda, et al.. (2013). Clonal Evolution In Aplastic Anemia Is Driven By Chromosomal Instability Rather Than Mutations In Myeloid Malignancy Candidate Gene. Blood. 122(21). 802–802. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026